Behçet Disease
·MeSH: Behcet Syndrome
Prevalence
5.0 / 100K
1 drug in development·1 company·2 clinical trials
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| dusquetide | SOLIGENIX, INC. (SNGX) |
Frequently asked questions
How many drugs are in development for Behçet Disease?
BioSniper tracks 1 drug in development for Behçet Disease across 1 company.
How many clinical trials target Behçet Disease?
There are 2 clinical trials targeting Behçet Disease tracked by BioSniper.
What is the prevalence of Behçet Disease?
The estimated prevalence of Behçet Disease is approximately 5.0 per 100,000 population.
Deep-dive into Behçet Disease
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis